SCHEMBL9696261

SCHEMBL9696261

CC(C)c1c(C#CCO[PH](=O)C[C@@H](O)CC(=O)O)c(-c2ccc(F)cc2)n2ccccc12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HMGCR P04035 10/20 0.39
CYP2C9 P11712 3/20 0.36
SIRT6 Q8N6T7 2/20 0.36
ABCB11 O95342 2/20 0.36
ABCC3 O15438 1/20 0.36
PGR P06401 1/20 0.36
ADORA3 P0DMS8 1/20 0.36
RXRA P19793 1/20 0.36
TBXA2R P21731 1/20 0.36
CCKAR P32238 1/20 0.36
ADRA1A P35348 1/20 0.36
PTGS2 P35354 1/20 0.36
NR4A2 P43354 1/20 0.36
PDE4D Q08499 1/20 0.36
SLC10A1 Q14973 1/20 0.36
NR1I2 O75469 1/20 0.35
RHOC P08134 1/20 0.35
CYP3A4 P08684 1/20 0.35
THRB P10828 1/20 0.35
HDAC1 Q13547 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9696267 1.00 HMGCR (0.39) HMGCRCYP2C9SIRT6ABCB11ABCC3
SCHEMBL9781044 0.85 HMGCR (0.30) HMGCR
SCHEMBL9696492 0.85 HMGCR (0.39) HMGCRCYP2C9SIRT6ABCB11ABCC3
SCHEMBL9696496 0.85 HMGCR (0.39) HMGCRCYP2C9SIRT6ABCB11ABCC3
SCHEMBL8953146 0.80 HMGCR (0.49) HMGCR
SCHEMBL8953145 0.80 HMGCR (0.49) HMGCR
SCHEMBL9696578 0.79 HMGCR (0.40) HMGCR
SCHEMBL9696587 0.79 HMGCR (0.40) HMGCR
SCHEMBL9696241 0.79 HMGCR (0.38) HMGCR
SCHEMBL9696601 0.78 KMT2A (0.38) HMGCR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5124453-A Treatment of corresponding aldehyde with lithium bis(tri-methylsilyl)amide E. R. SQUIBB & SONS, INC. (US) 1992-06-23 US disclosed
EP-0444532-A1 Phosphorus-containing HMG-CoA reductase inhibitors, new intermediates and method E.R. SQUIBB & SONS, INC. (US) 1991-09-04 EP disclosed
US-5025000-A Anticholesterol, antilipemic agents E. R. SQUIBB & SONS, INC. (US) 1991-06-18 US disclosed